CLN8
protein-codingCLN8 transmembrane ER and ERGIC protein, the group of TLC domain containing
Gene summary
This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
- EPMR
- C8orf61
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~45.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010830
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0016295
Submitter: ClinGen
CLN8 was first reported in relation to autosomal recessive neuronal ceroid lipofuscinosis (NCL) in 1999 (Ranta et al., PMID: 10508524). At least 50 variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 10 unrelated probands in 5 publications (PMID: 10508524, 15024724, 19201763, 19807737, 26075876). More evidence is available in the literature, but the maximum score for genetic evidence and/or experimental evidence (12 pts.) has been reached. The mechanism for disease is homozygous loss of function. Of note, the founder variant c.70C>G p.R24G in CLN8 has been implicated in the Northern epilepsy variant of NCL, a slightly more mild and protracted presentation of NCL. Since these patients have intraneuronal brain pathology similar to other patients with classic NCLs (PMID: 10764041), we have “lumped” the conditions for curation. This gene-disease association is supported by a spontaneous non-human animal (dog) model with vision loss, ataxia, and spontaneous seizures (PMID: 24953404). In summary, CLN8 is definitively associated with autosomal recessive NCL. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Epilepsy Working Group on 9/1/20 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0010830
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0012391
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0010830
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0012391
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0005258
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0010830
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0010830
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0010830
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CLN8 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018941.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 201 | 1 | 205 | ||
| missense | 3 | 27 | 234 | 10 | 3 | 277 |
| nonsense | 22 | 7 | 2 | 31 | ||
| start loss | 2 | 2 | 4 | |||
| frameshift | 14 | 15 | 2 | 31 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | 8 | ||
| Total | 42 | 54 | 245 | 211 | 4 | 556 |
Highest pathogenic variant AF is 0.000042136417
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061764.2 | 2 | MANE Select | |
| Ensembl | ENSP00000328182.4 | 2 | MANE Select | |
| Ensembl | ENSP00000490016.1 | 2 | Standard | |
| Ensembl | ENSP00000490016.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Synaptic Vesicle Pathway
Biological Process
- age-dependent response to oxidative stress
- phospholipid metabolic process
- ceramide metabolic process
- lipid transport
- mitochondrial membrane organization
Cellular Component
- mitochondrion
- endoplasmic reticulum
- endoplasmic reticulum membrane
- endoplasmic reticulum-Golgi intermediate compartment
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000331222
- Coding exons
- 2
- Length
- 30795
- Individuals with no LoFs
- 125734
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 14
- Defined
- 125748
- p
- 0.0000557
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.766 | 200 | 172 | 1.16 | 0.0000108 | 1879 |
| Missense (PolyPhen) | 59 | 66.072 | 0.89296 | 755 | ||
| Synonymous | -2.34 | 102 | 76.0 | 1.34 | 0.00000519 | 586 |
| Loss of Function | 1.22 | 5 | 8.95 | 0.559 | 3.90e-7 | 86 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000088 | 0.000088 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Could play a role in cell proliferation during neuronal differentiation and in protection against cell death. {ECO:0000269|PubMed:19431184}.;
- Disease
- DISEASE: Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]: A form of neuronal ceroid lipofuscinosis with onset in childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 8 comprise mixed combinations of granular, curvilinear, and fingerprint profiles. {ECO:0000269|PubMed:15024724, ECO:0000269|PubMed:16570191, ECO:0000269|PubMed:19201763, ECO:0000269|PubMed:19431184, ECO:0000269|PubMed:19807737, ECO:0000269|PubMed:21990111, ECO:0000269|PubMed:26443629}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant (CLN8NE) [MIM:610003]: A form of neuronal ceroid lipofuscinosis clinically characterized by epilepsy that presents between 5 and 10 years of age with frequent tonic-clonic seizures followed by progressive mental retardation. Visual loss is not a prominent feature. Intracellular accumulation of autofluorescent material results in curvilinear and granular profiles on ultrastructural analysis. {ECO:0000269|PubMed:10508524, ECO:0000269|PubMed:21990111}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.142
- RVIS EVS
- -0.14
- RVIS percentile EVS
- 43.77
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.160
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |